Intraocular Lens Market Scope
An intraocular lens is defined as the lens which is implanted in the eye as part of a treatment for various eye diseases such as cataracts, myopia, among others. It is mainly implanted for the duration of cataract surgery after the cloudy eye's natural lens has been removed. Geriatric population and associated eye disorders, rising prevalence of eye diseases & diabetes in the overall population are the major drivers which are propelling the growth of the market. The market for the intraocular lens is anticipated to register a CAGR of over 6.2% during the forecast period
The market study is being classified by Type (Traditional/Monofocal, Premium and Phakic), by Application (Hydrophilic and Hydrophobic) and major geographies with country level break-up.
The market is fragmented with numerous players focusing on technique and quality of the product due to which the global intraocular lenses market can witness an upsurge in the forecast period. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Intraocular Lens market throughout the predicted period.
Alcon, Inc. (United States), Novartis AG (Switzerland), Bausch + Lomb (United States), Valeant Pharmaceuticals International (Canada), Johnson & Johnson Vision Care, Inc. (United States), Carl Zeiss Meditec (Germany), HOYA Corporation (Japan), STAAR Surgical Company (United States), Rayner Intraocular Lenses Limited (United Kingdom) and PhysIOL (Belgium) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Ophtec BV (Netherlands), Swiss Advanced Vision (Switzerland), Oculentis GmbH (Germany), NIDEK CO., LTD. (Japan), Aurolab (India), Omni Lens Pvt Ltd. (India), Care Group (India), Hanita Lenses R.C.A Ltd. (Israel) and Fred Hollows Intraocular Laboratory (Eritrea).
AdvanceMarketAnalytics has segmented the market of Global Intraocular Lens market by Type, Application and Region.
On the basis of geography, the market of Intraocular Lens has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Material, the sub-segment i.e. PMMA will boost the Intraocular Lens market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospital and Clinic will boost the Intraocular Lens market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
In February 2017, Johnson & Johnson (United States) Company has acquired Abbott Medical Optics (United States). This Acquisition of Abbott Medical Optics will help in expanding Johnson & Johnsonís ophthalmic product offerings in cataract surgery, laser refractive surgery as well as consumer eye health. Henceforth, it will affect the growth of the market in future. and In April 2016, the Alcon (United States) Company has entered into a strategic partnership with PowerVision, Inc. (United States) Company in order to develop fluid-based accommodating intraocular lenses (AIOL) for cataract patients. Therefore, this partnership will help in strengthening the position of the company in the United States
In October 2017, the Bausch + Lomb (United States) Company launched the enVista MX60E, a hydrophobic, acrylic advanced optic (AO) IOL with StableFlex technology in order to provide controlled unfolding, excellent stability, as well as enhanced optic recovery. Hence, this would strengthen the companyís product portfolio. and In October 2017, the Carl Zeiss Meditec AG (Germany) Company has launched the AT LARA, which is the Extended Depth of Focus (EDoF) IOL. Therefore, this product launch allowed the company to strengthen its intraocular lens products portfolio in the United States.
- Technological Advancement in Intraocular Lens
- Rising Prevalence of Eye Diseases Worldwide
- Government and Awareness Initiatives to Control and Treat Blindness
- Technological Advancements in IOLs
- Rising Demand from Emerging Economics such as China and India
- Lack of Proper Coverage or Co-Payment Policies for Premium IOLs
- Issue related to Scarcity of Ophthalmologists
Key Target AudienceIntraocular Lenses (IOLs) Manufactures, Intraocular Lenses (IOLs) Suppliers and Distributors, Healthcare Service Providers (Including Hospitals, Eye Clinics, and Public and Private Eye Care Centers), Government Associations, Health Insurance Provider Companies, Market Research and Consulting Firms and Venture Capitalists and Investors
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase